Fluoroquinolone-resistant Enterobacterales
Showing 1 - 25 of 5,447
Colonization With Resistant Enterobacterales in Neutropenic
Completed
- Hematologic Malignancy
- +3 more
- No intervention.
-
San Francisco, California
- +5 more
Apr 5, 2022
Household Transmission Dynamics of Multidrug Resistant
Not yet recruiting
- Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
- (no location specified)
Apr 3, 2023
Colonization, Asymptomatic Trial in Bangkok (Neomycin)
Recruiting
- Colonization, Asymptomatic
-
Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Nov 24, 2022
Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia Trial in Nankoku
Recruiting
- Complicated Urinary Tract Infection
- +4 more
- co-administration of cefepime and nacubactam
- +2 more
-
Nankoku, Kochi, JapanMeiji Research Site
Jun 6, 2023
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- CAZ/AVI plus Aztreonam
- Conventional treatment
-
Jinan, Shandong, ChinaMingju Hao
Apr 29, 2023
Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection Trial (Rapid Diagnostics)
Not yet recruiting
- Blood Stream Infections
- +4 more
- Rapid Diagnostics
- (no location specified)
Jul 31, 2023
Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection Trial in Porto Alegre (Meropenem)
Terminated
- Carbapenem-Resistant Enterobacteriaceae Infection
- Bloodstream Infection
-
Porto Alegre, RS, Brazil
- +1 more
Aug 1, 2022
Fluoroquinolone Resistance Prevalence Study
Recruiting
- Multiple Myeloma
-
Washington, District of Columbia
- +1 more
Apr 10, 2023
Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection Trial (Pivmecillinam and amoxicillin/clavulanic acid,
Not yet recruiting
- Urinary Tract Infections
- +2 more
- Pivmecillinam and amoxicillin/clavulanic acid
- Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility
- (no location specified)
Nov 18, 2022
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
Resistance in Carbapenemase-producing Enterobacterales and
Enrolling by invitation
- Bacterial Infections
- Antibiotic Resistant Infection
- No intervention
-
Rio De Janeiro, BrazilD'Or Institute for Research and Education (IDOR)
Mar 16, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Sepsis, Hemodynamic Instability, Bacterial Infections Trial in Singapore (Therapeutic Drug Monitoring (TDM))
Recruiting
- Sepsis
- +4 more
- Therapeutic Drug Monitoring (TDM)
-
Singapore, SingaporeSingapore General Hospital
Jul 17, 2023
Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)
Withdrawn
- Bacteremia Caused by Gram-Negative Bacteria
-
Newcastle, New South Wales, Australia
- +28 more
May 17, 2022
Multidrug Resistant Organisms, Faecal Microbiota Transplantation Trial in Hvidovre (Faecal microbiota transplantation, Placebo)
Not yet recruiting
- Multidrug Resistant Organisms
- Faecal Microbiota Transplantation
- Faecal microbiota transplantation
- Placebo
-
Hvidovre, Copenhagen, DenmarkHvidovre Hospital, Copenhagen University
Feb 27, 2023
Patients With Infection by Resistant Microorganism
Enrolling by invitation
- Pneumonia
- +10 more
- Pathogen resistant phenotype
-
Sevilla, SpainHospital Universitario Virgen Macarena
May 18, 2023
Cost-effectiveness of Controlling CPE
Not yet recruiting
- Carbapenemase-producing Enterobacteriaceae Infections
- (no location specified)
Feb 28, 2022
Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary
Not yet recruiting
- Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections
- antibiotic sensitivity
-
Sohag, EgyptSohag University Hospital
Apr 13, 2023
FQ Restriction for the Prevention of CDI
Enrolling by invitation
- Clostridium Difficile
- +2 more
- fluoroquinolone preprescription authorization
- Control
-
Phoenix, Arizona
- +7 more
Mar 2, 2022
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Febrile Neutropenia Trial (Early Discontinuation of Antibiotics, Standard of Care)
Not yet recruiting
- Febrile Neutropenia
- Early Discontinuation of Antibiotics
- Standard of Care
- (no location specified)
Mar 24, 2023
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023
Primary Clostridioides Difficile Infection (pCDI) Trial (Lyophilized fecal microbiome transfer, Vancomycin)
Not yet recruiting
- Primary Clostridioides Difficile Infection (pCDI)
- Lyophilized fecal microbiome transfer
- Vancomycin
- (no location specified)
Jan 24, 2023
